These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23890249)

  • 41. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 44. Generation of retinal cells from pluripotent stem cells.
    Jin ZB; Takahashi M
    Prog Brain Res; 2012; 201():171-81. PubMed ID: 23186714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Geographic atrophy: clinical impact and emerging treatments.
    Patel HR; Hariprasad SM; Eichenbaum D
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):8-13. PubMed ID: 25559503
    [No Abstract]   [Full Text] [Related]  

  • 46. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
    Singh MS; MacLaren RE
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment for atrophic macular degeneration.
    Meleth AD; Wong WT; Chew EY
    Curr Opin Ophthalmol; 2011 May; 22(3):190-3. PubMed ID: 21427574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration.
    Wei CX; Sun A; Yu Y; Liu Q; Tan YQ; Tachibana I; Zeng H; Wei JY
    Adv Exp Med Biol; 2016; 854():103-9. PubMed ID: 26427400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Which stem cells to repair the endocrine pancreas?].
    Duvillié B
    Med Sci (Paris); 2013; 29(8-9):744-8. PubMed ID: 24005629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Embryonic and adult stem cell therapy.
    Brignier AC; Gewirtz AM
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S336-44. PubMed ID: 20061008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac cell therapies: the next generation.
    Choi YH; Saric T; Nasseri B; Hühn S; Van Linthout S; Hetzer R; Tschöpe C; Stamm C
    Cardiovasc Ther; 2011 Feb; 29(1):2-16. PubMed ID: 20946322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem cell therapies for treating osteoarthritis: prescient or premature?
    Whitworth DJ; Banks TA
    Vet J; 2014 Dec; 202(3):416-24. PubMed ID: 25457267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice.
    Assawachananont J; Mandai M; Okamoto S; Yamada C; Eiraku M; Yonemura S; Sasai Y; Takahashi M
    Stem Cell Reports; 2014 May; 2(5):662-74. PubMed ID: 24936453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of retinal cells from mouse and human induced pluripotent stem cells.
    Hirami Y; Osakada F; Takahashi K; Okita K; Yamanaka S; Ikeda H; Yoshimura N; Takahashi M
    Neurosci Lett; 2009 Jul; 458(3):126-31. PubMed ID: 19379795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kidney repair using stem cells: myth or reality as a therapeutic option?
    Iwatani H; Imai E
    J Nephrol; 2010; 23(2):143-6. PubMed ID: 20175054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo differentiation of human embryonic stem cells into retina-like organs and comparison with that from mouse pluripotent epiblast stem cells.
    Aoki H; Hara A; Niwa M; Yamada Y; Kunisada T
    Dev Dyn; 2009 Sep; 238(9):2266-79. PubMed ID: 19544586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.
    Wiley LA; Burnight ER; Songstad AE; Drack AV; Mullins RF; Stone EM; Tucker BA
    Prog Retin Eye Res; 2015 Jan; 44():15-35. PubMed ID: 25448922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.
    Fung RK; Kerridge IH; Skene LL; Munsie MJ
    Med J Aust; 2012 Jun; 196(10):622-5. PubMed ID: 22676869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.